This news is for Australian Media only Eflornithine is now reimbursed by the government under Australia's Pharmaceutical Benefits Scheme (PBS).

DelveInsight's KIT Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Safe Harbor announces expansion into the Mediterranean with the acquisition of Monaco Marine, adding to its unmatched global ...

According to the latest study from BCC Research, the "Oncology Diagnostics: Global Markets" is projected to increase from $77 ...

Flo Health, the world's leading women's health app, announced today that they have agreed to settle a class action lawsuit. The settlement ...

Digital asset technology developer The Apertum Foundation and its senior advisor, Josip Heit, have prevailed in their ...

The global Pharmaceutical Metal Detector Market, valued at US$151.7 million in 2024 stood at US$157.1million in 2025 and is projected ...

SkyQuest Technology Consulting published a report, titled, Contract Research Organization Market - Global Opportunity ...

Quadrants has released its latest Smart Pills Startups/SMEs Companies Assessment, recognizing key players, including both global giants ...

PRNewswire/ -- e& today announced its consolidated financial results for the first half of 2025, reporting continued growth momentum and strategic ...

SkyQuest Technology Consulting published a report, titled, Industrial Automation Market - Global Opportunity Analysis and ...

The global Cell Culture Market, valued at US$27.92 billion in 2024 stood at US$29.76 billion in 2025 and is projected to advance at a ...